Generic

Mylan Will Pay $96.5M to Settle Provigil Suit

Feb 07, 2017

Bloomberg

Mylan agreed to pay $96.5 million to settle decade-long litigation claiming the company conspired with Cephalon to delay a generic version of Mylan's narcolepsy drug.

The lawsuit claimed that Mylan paid pharmaceutical company Cephalon (now owned by Teva) to delay the entry to market of its generic version of Provigil, owned by Mylan at the time.

The case began in April of 2006. Per the settlement, Mylan will pay all persons or entities in the U.S. and its territories who bought Provigil in any form directly from Cephalon at any time from June 24, 2006 through Aug. 31, 2012.

Read the Bloomberg coverage